Ototoxic potential of gentamicin in ponies.

The study revolves around the impacts of the antibiotic gentamicin on the auditory function in ponies. Though administrated at or even above the typical therapeutic dosage, the ponies showed no signs of auditory dysfunction or other side effects, marking gentamicin as a minimal risk medication for ponies.

Study Design and Process

• The test subjects of this study were six healthy ponies, which were divided into two groups. Ponies in the first group were given the drug for 7 days and the second for 14 days. The dosage of gentamicin was standardized at 5 mg per kg of the pony’s body weight, given every 8 hours through intramuscular injection.
• The researchers monitored the levels of gentamicin in the ponies’ bodies by measuring serum peak and trough concentrations regularly, using a test known as a radioimmunoassay. This is a simple and sensitive method that allows for accurate measurement of very low levels of substances in biological samples.
• They also carefully observed any potential indications of renal toxicity (nephrotoxicosis), by analyzing serum chemical values, due to the fact that gentamicin, like other aminoglycosides, has the potential to cause kidney damage.

Results and Findings

• Over the course of the study, the serum gentamicin concentration levels in the ponies were either within or even above the accepted clinical therapeutic range. This means that the dosage they were given was confirmed to be a strong one, comparable to that which might be used in clinical treatment.
• The primary parameter of interest, auditory function, was tested every five days until 60 days after the first dose. Brain stem auditory-evoked responses (a measure of the electrical signals in the auditory nerve) were used to do this. The frequency range tested was between 1 to 4 kHz, which is a common frequency range for hearing tests.
• In spite of the heavy dosage of gentamicin and the thorough testing, there was no loss of auditory function observed in any of the ponies throughout the experiment. Similarly, there was no evidence of nephrotoxicosis, and all other test parameters remained within their normal ranges.
• These results indicate that gentamicin seems to have a minimal risk of ototoxic (ear-damaging) or other side effects when given through intramuscular injection to healthy ponies.